Dong, K. (2019) “Efficacy and safety of regorafenib versus dinutuximab with chemotherapy in Chinese children with neuroblastoma”, Bangladesh Journal of Pharmacology, 14(1), pp. 32–35. doi: 10.3329/bjp.v14i1.38807.